Oncotelic Therapeutics Inc OTLC:OTCQB

*Data is delayed | Exchange | USD
Last | 1:34 PM EDT
0.0388quote price arrow down-0.0012 (-2.8786%)
Volume
1,267
52 week range
0.01 - 0.05
Loading...
  • Open0.0388
  • Day High0.0388
  • Day Low0.0388
  • Prev Close0.0399
  • 52 Week High0.05
  • 52 Week High Date10/19/23
  • 52 Week Low0.01
  • 52 Week Low Date06/27/23

Key Stats

  • Market Cap15.508M
  • Shares Out399.68M
  • 10 Day Average Volume32,882.11
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change1.44

KEY STATS

  • Open0.0388
  • Day High0.0388
  • Day Low0.0388
  • Prev Close0.0399
  • 52 Week High0.05
  • 52 Week High Date10/19/23
  • 52 Week Low0.01
  • 52 Week Low Date06/27/23
  • Market Cap15.508M
  • Shares Out399.68M
  • 10 Day Average Volume32,882.11
  • Dividend-
  • Dividend Yield-
  • Beta0.04
  • YTD % Change1.44

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-2.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-601,859.987
  • ROE (TTM)-50.12%
  • Revenue (TTM)70,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-11,722.94%
  • Debt To Equity (MRQ)103.66%

EVENTS

  • Earnings Date05/17/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncotelic Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer. The Company has eight primary drug and AI technology programs: AL-101, an intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction...
Vuong Trieu Ph.D.
Chairman of the Board, Chief Executive Officer
Amit Shah
Chief Financial Officer
Address
29397 Agoura Road Suite 107
Agoura Hills, CA
91301
United States

Top Peers

SYMBOLLASTCHG%CHG
ALZN
Alzamend Neuro Inc
0.72+0.009+1.2658%
NERV
Minerva Neurosciences Inc
2.36UNCHUNCH
VINC
Vincerx Pharma Inc
0.8595+0.0325+3.9299%
COCP
Cocrystal Pharma Inc
1.52-0.03-1.94%
PMCB
PharmaCyte Biotech Inc
2.13+0.01+0.48%